|PROXIMAGEN LTD. Patent applications|
|Patent application number||Title||Published|
|20140107150||New Compounds II - The present invention relates to compounds of formula (I),||04-17-2014|
|20100216878||Amino Acid Derivatives - The compound 3,3-dimethyl-butyric acid 4-((S)-2-amino-2-methoxycarbonyl-ethyl)-2-(3,3-dimethyl-butyryloxy)-phenyl ester of formula (I) has dopaminergic properties.||08-26-2010|
|20100190725||AMINO ACID DERIVATIVES - Compounds of formula (I) or formula (II) have dopaminergic activity: wherein: R||07-29-2010|
|20090239941||AMINO ACID DERIVATIVES - Compounds of formula (I) are active as dopaminergic compounds or as compounds which or as compounds which diminish the symptoms of dopamine deficiency: wherein: R||09-24-2009|
|20090170937||Amino Acid Derivatives - Compounds of formula (I) have activity in alleviating the effects of impaired dopaminergic signaling, for example in the treatment of Parkinsons Disease:||07-02-2009|
Patent applications by PROXIMAGEN LTD.